These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19050794)

  • 1. Angiogenesis and co-expressed of ER and c-erbB-2 (HER2/neu) protein in primary breast cancer patients: an analysis of 158 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2008; 49(4):469-78. PubMed ID: 19050794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and c-erbB-2 (HER2/neu) overexpression status in primary breast cancer patients: an analysis of 158 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2007; 48(2):121-9. PubMed ID: 17641798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and progesterone receptor status in primary breast cancer patients: an analysis of 158 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2007; 48(3):267-74. PubMed ID: 17914494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis and tumor grading in primary breast cancer patients: an analysis of 158 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2006; 47(3):251-7. PubMed ID: 17308684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2007; 48(1):25-31. PubMed ID: 17502947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2008; 49(2):181-8. PubMed ID: 18516324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?
    Jacobs TW; Siziopikou KP; Prioleau JE; Raza S; Baum JK; Hayes DF; Schnitt SJ
    Mod Pathol; 1998 Mar; 11(3):259-64. PubMed ID: 9521472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.
    Barnes PJ; Boutilier R; Chiasson D; Rayson D
    Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.
    McCarthy NJ; Yang X; Linnoila IR; Merino MJ; Hewitt SM; Parr AL; Paik S; Steinberg SM; Hartmann DP; Mourali N; Levine PH; Swain SM
    Clin Cancer Res; 2002 Dec; 8(12):3857-62. PubMed ID: 12473600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA; Mamoon N; Mushtaq S; Khadim MT
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2/neu expression in relation to clinicopathologic features of breast cancer patients.
    Traina A; Agostara B; Marasà L; Calabrò M; Zarcone M; Carruba G
    Ann N Y Acad Sci; 2006 Nov; 1089():159-67. PubMed ID: 17261764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.
    D'Alessandro C; Dellapasqua S; Orlando L; Santoro L; Maisonneuve P; Torrisi R; Balduzzi A; Scarano E; Ghisini R; Peruzzotti G; Goldhirsch A; Colleoni M
    Breast J; 2008; 14(5):435-41. PubMed ID: 18821931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast.
    Jitsuiki Y; Hasebe T; Tsuda H; Imoto S; Tsubono Y; Sasaki S; Mukai K
    Mod Pathol; 1999 May; 12(5):492-8. PubMed ID: 10349987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer.
    Chan JK; Loizzi V; Magistris A; Lin F; Rutgers J; Osann K; Disaia PJ; Berman ML
    Clin Cancer Res; 2004 Dec; 10(24):8538-43. PubMed ID: 15623636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
    Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
    Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients.
    Dillon MF; Stafford AT; Kelly G; Redmond AM; McIlroy M; Crotty TB; McDermott E; Hill AD; Young LS
    Endocr Relat Cancer; 2008 Sep; 15(3):745-53. PubMed ID: 18469157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
    Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
    J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls.
    Moriki T; Takahashi T; Ueta S; Mitani M; Ichien M
    Diagn Cytopathol; 2004 Apr; 30(4):251-6. PubMed ID: 15048960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high copy number of HER2 associated with polysomy 17 on HER2 protein expression in invasive breast carcinoma.
    Shah SS; Wang Y; Tull J; Zhang S
    Diagn Mol Pathol; 2009 Mar; 18(1):30-3. PubMed ID: 19214111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.